weight regain and cardiometabolic effects after withdrawal of semaglutide Why Most Diets Fail Weight regain and cardiometabolic effects

CI: confidence interval

ABSTRACT Glucagon-like peptide-1 receptor (Glp1r) agonists have transformed obesity treatment, but weight loss responses to these drugs vary widely

This step ensures safety and clarity before treatment begins

Revised: June/2026 Instructions for Use 0.25 mg, 0.5 mg, 1 mg single-dose prefilled syringe PRINCIPAL DISPLAY PANEL 0.25 mg or 0.5 mg doses, 2 mg/3mL Pen 0.25 mg 0.5 mg NDC 0169-4181-13List 418113 OZEMPIC (semaglutide) injection For Single Patient Use Only 2 mg/3 mL (0.68 mg/mL) Prefilled pen Pen delivers doses in 0.25 mg or 0.5 mg increments only For subcutaneous use only Use OZEMPIC once weekly Contains: 1 OZEMPIC pen, 6 NovoFine Plus 32G needles, Product Literature

Pharmaceutical firm Novo Nordisk makes semaglutide, but its patent expires in India this month, where there has been a major rush from local manufacturers to mass produce cheaper versions